Table E6.
Mortality and mitral valve reintervention at 3 years and long-term among patients who received TEER stratified MR ≤1.5 and MR ≥2.0
| Overall | MR ≤1.5 | MR ≥2.0 | P value | |
|---|---|---|---|---|
| Death | ||||
| 3-y | 37.9% (61) | 35.3% (41) | 44.4% (20) | .37 |
| Long-term | 30.0% (80) | 25.6% (51) | 42.6% (29) | .008 |
| Average days of follow-up | 697.6 ± 478.1 (median, 662) | 696.7 ± 473.8 (median, 660) | 700.4 ± 494.0 (median, 681.5) | .98 |
| Average days to death | 572.2 ± 420.6 (median, 618.5) | 502.2 ± 351.8 (median, 519) | 695.3 ± 503.6 (median, 707) | .14 |
| Adjusted HR (95% CI), P-value | 3-y: HR, 1.63 (0.99-2.68), P = .05 | Long-term: HR, 1.47 (0.92-2.34), P = .11 | ||
| Follow-up mitral valve intervention | ||||
| 3-y | 9.3% (15) | 10.3% (12) | 6.7% (3) | .35 |
| Long-term | 7.5% (20) | 7.5% (15) | 7.4% (5) | 1.00 |
| Average days to follow-up mitral intervention | 173.3 ± 193.8 (median, 119.5) | 183.2 ± 215.6 (median, 108.0) | 143.6 ± 119.0 (median, 131.0) | 1.00 |
| Adjusted HR (95% CI), P-value | 3-y: HR, 1.05 (0.35-3.18), P = .93 | Long-term: HR, 1.06 (0.35-3.22), P = .92 | ||
Outcome frequencies are presented as % (n). A total of 161 patients had the opportunity for 3 years of follow-up (MR ≤1.5, n = 116; MR ≥2.0, n = 45). MR, Mitral regurgitation; HR, hazard ratio; CI, confidence interval; TEER, transcatheter edge-to-edge mitral valve repair.